Diverse Roles of Interleukin 17 Isoforms in the Pathogenesis of Hypertension

白细胞介素 17 亚型在高血压发病机制中的多种作用

• 批准号: 9275079
• 负责人: Meenakshi Swaminathan Madhur
• 金额: $ 9.69万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-02-01 至 2019-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9275079
• 关键词: Acute; Adult; Allergic; Angiotensin II; Antibodies; Appointment; Autoimmune Diseases; Autoimmune Process; Blood Pressure; Blood Vessels; CD4 Positive T Lymphocytes; CD8-Positive T-Lymphocytes; CD8B1 gene; Cardiology; Cardiovascular Diseases; Cells; Chronic; Chronic Kidney Failure; Clinical Pharmacology; Data; Disease; Doctor of Philosophy; Drug Targeting; Endothelial Cells; Environment; Etiology; FDA approved; Faculty; Fellowship; Functional disorder; Funding; Gene Expression; General Population; Genetic; Goals; Grant; Health; Helper-Inducer T-Lymphocyte; Homologous Gene; Human; Human Resources; Hypertension; IL17 gene; IL4 gene; IL5 gene; Immune; Immune system; Immunology; Impaired Renal Function; Individual; Infiltration; Inflammation; Inflammatory; Inflammatory Response; Infusion procedures; Injury; Interferon Type II; Interleukin-12; Interleukin-17; Interleukins; Internal Medicine; Kidney; Knockout Mice; Laboratories; Lead; Mediating; Medical; Mentors; Mentorship; Morbidity - disease rate; Multiple Sclerosis; Mus; Nephrology; Nuclear; Organ; Pathogenesis; Pathway interactions; Pharmaceutical Preparations; Play; Postdoctoral Fellow; Production; Protein Isoforms; Psoriasis; Reactive Oxygen Species; Regulation; Renal function; Research; Research Personnel; Residencies; Resources; Rheumatoid Arthritis; Risk Factors; Role; Scientist; Serum; Smooth Muscle Myocytes; Societies; Stroke; Structure; Superoxides; Systemic blood pressure; T-Lymphocyte; Th1 Cells; Th2 Cells; Therapeutic; Time; Training; Training Programs; Universities; Vascular Diseases; Virginia; Widespread Disease; base; blood pressure reduction; blood pressure regulation; career; career development; clinical investigation; cytokine; hypertension control; hypertension treatment; inhibiting antibody; insight; interest; kidney vascular structure; meetings; member; mortality; neutralizing antibody; new therapeutic target; normotensive; novel; novel therapeutics; professor; receptor; response; vascular inflammation

DESCRIPTION (provided by applicant): The applicant, Dr. Madhur, is a new Assistant Professor in the Divisions of Clinical Pharmacology and Cardiology at Vanderbilt University. She obtained her MD/PhD degrees from the University of Virginia Medical Scientist Training Program and completed her Internal Medicine residency at Duke University followed by a research track Cardiology Fellowship at Emory University. During her post-doctoral fellowship at Emory, in the laboratory of Dr. David Harrison, she became interested in the role of the immune system in hypertension. Emerging evidence indicates that hypertension is an inflammatory disease. Dr. Madhur was the first to demonstrate a critical role for the pro-inflammatory cytokine, interleukin 17A (IL17A), in angiotensin II induced hypertension and vascular dysfunction. Moreover, she showed that serum levels of IL17A were increased in humans with hypertension compared to normotensive individuals. There are 6 isoforms of IL17, designated IL17A through F, of which IL17A and F are most closely related in terms of structure, function, and expression. IL17F levels are increased in IL17A deficient mice, suggesting coordinate regulation, yet the role of IL17F in hypertension is unknown. As an Assistant Professor, under the continued mentorship of Dr. Harrison, the applicant plans to further investigate the role of the interleukin 17 pathway in hypertension and the associated end organ dysfunction using a combination of genetic knockout mice and neutralizing antibodies to IL17 and related cytokines. She has preliminary data that IL17F, contrary to IL17A, may serve a protective role in hypertension and the associated inflammatory response. This finding is exciting and has important therapeutic implications in terms of identifying specific antibody based drug targets for hypertension. One focus of the current proposal is to determine the effect of IL17 isoforms on renal dysfunction in hypertension. To assist in this aspect of the project, she has chosen a co-mentor, Dr. Raymond Harris, who is the Chief of Nephrology at Vanderbilt and has expertise in mechanisms of acute and chronic kidney injury. The studies outlined in this proposal will expand our understanding of the pathophysiology of hypertension and potentially lead to the identification of novel therapeutic targets for this widespread disease. Dr. Madhur's current academic appointment provides 80% protected research time as well as laboratory space, start-up funds, and access to core resources and support personnel to carry out the proposed studies. She has hired a post-doctoral fellow who will be assisting her on the projects outlined in this grant. Vanderbilt offers an exceptional research and intellectual environment for early career development. The applicant's training plan includes didactic courses, lab meetings, university seminars, national meetings, participation in Vanderbilt societies to promote the retention and tenure of junior faculty members, a mentoring committee, and one-on-one mentorship and guidance from both mentors. Dr. Madhur's long-term career goal is to establish herself as an independent clinician-investigator bridging the fields of hypertension and immunology.

描述（由申请人提供）：申请人Madhur博士是范德比尔特大学临床药理学和心脏病学系的新助理教授。她获得了弗吉尼亚大学医学科学家培训计划的医学博士/博士学位，并在杜克大学完成了内科住院医师培训，随后在埃默里大学获得了心脏病学研究奖学金。在埃默里大学的博士后研究期间，在大卫哈里森博士的实验室里，她对免疫系统在高血压中的作用产生了兴趣。新的证据表明，高血压是一种炎症性疾病。Madhur博士是第一个证明促炎细胞因子白细胞介素17 A（IL 17 A）在血管紧张素II诱导的高血压和血管功能障碍中的关键作用的人。此外，她表明，与血压正常的个体相比，高血压患者的血清IL 17 A水平升高。IL 17有6种亚型，命名为IL 17 A至F，其中IL 17 A和F在结构、功能和表达方面最密切相关。IL 17 F水平在IL 17 A缺陷小鼠中增加，表明协调调节，但IL 17 F在高血压中的作用尚不清楚。作为助理教授，在Harrison博士的持续指导下，申请人计划使用基因敲除小鼠和IL 17和相关细胞因子的中和抗体的组合进一步研究白细胞介素17通路在高血压和相关终末器官功能障碍中的作用。她有初步的数据表明，与IL 17 A相反，IL 17 F可能在高血压和相关的炎症反应中起保护作用。这一发现是令人兴奋的，并在确定基于特异性抗体的药物靶点方面具有重要的治疗意义， 高血压目前建议的一个重点是确定IL 17亚型对高血压肾功能不全的影响。为了协助该项目的这一方面，她选择了一位共同导师Raymond Harris博士，他是范德比尔特的肾脏科主任，在急性和慢性肾损伤机制方面具有专业知识。本提案中概述的研究将扩大我们对高血压病理生理学的理解，并可能导致确定这种广泛疾病的新治疗靶点。Madhur博士目前的学术任命提供了80%的受保护的研究时间以及实验室空间，启动资金，并获得核心资源和支持人员来开展拟议的研究。她已经聘请了一名博士后研究员，他将协助她完成 这个grant。范德比尔特为早期职业发展提供了一个特殊的研究和智力环境。申请人的培训计划包括教学课程，实验室会议，大学研讨会，全国会议，参加范德比尔特协会，以促进初级教师的保留和任期，指导委员会，以及一对一的指导和指导。Madhur博士的长期职业目标是成为一名独立的临床研究者，在高血压和免疫学领域架起桥梁。